Metoclopramide
- PDF / 151,464 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 103 Downloads / 212 Views
1 S
Atrial fibrillation: case report A 60-year-old man developed atrial fibrillation (AF) during treatment with metoclopramide for vomiting. The man, who was a smoker, presented to the emergency department (ED) of a hospital in United Arab Emirates, with dizziness and vomiting for a few hours. His medical history was significant for dyslipidaemia, type II diabetes mellitus and excessive alcohol consumption. On presentation, his vital signs were normal and hysical examination for cardiovascular and neurological systems was unremarkable. ECG revealed sinus rhythm with no ischaemic changes. He had repetitive vomiting; hence, IV metoclopramide 10mg was administered by the ED nurse. Within 5 min of the start of metoclopramide, his pulse rate went up to 150 /min indicating AF on the cardiac monitor. He was not in any distress and denied worsening of any other complaints. Repeat vital signs were satisfactory. Physical examination was unremarkable for cardiovascular, respiratory and neurological signs. Therefore, the AF was considered to be stable. The man was given a dose of unspecified β-blocker for rate control. Chest X-ray was also unremarkable. For observation and further evaluation, he was shifted to the telemetry unit for 24h. Within 24h, his atrial fibrillation reverted to sinus rhythm. On the next day, he was discharged uneventfully. Saleh AS, et al. Metoclopramide-induced atrial fibrillation: A case report. European Journal of Emergency Medicine: Official Journal of the European Society for Emergency 803520307 Medicine 27 (Suppl.): e12-e13, Aug 2020. Available from: URL: http://doi.org/10.1097/MEJ.0000000000000743 [abstract]
0114-9954/20/1834-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
Reactions 12 Dec 2020 No. 1834
Data Loading...
